Medical Marijuana, Inc. Announces Historic Registration of its CBD Products in Paraguay as a Medicine
?Medical Marijuana, Inc.?(OTC: MJNA), the first publicly traded cannabis company in?the United States, today announced the historic registration of its?Real Scientific Hemp Oil-X? (RSHO-X?)?and RSHO?-Blue Label CBD products as registered medicines by?Paraguay’s?national health regulation organization (Direcci?n Nacional de Vigilancia Sanitaria).
“We are a Company of firsts and we are excited about this new historic milestone of being the first company to have a CBD product registered in?Paraguay,” said Medical Marijuana, Inc. CEO Dr.?Stuart Titus.
Paraguay’s?official registration of Medical Marijuana, Inc.’s CBD hemp oil products marks the first country that has registered and approved the Company’s products as medicinal products. Currently, Medical Marijuana, Inc.’s CBD hemp oil products have been used in?Paraguay?with medical indications ranging from cancer, pain, multiple sclerosis, epilepsy and various other neurological diseases.
Prior to becoming registered as official medicines, in May of 2016, Real Scientific Hemp Oil? became the first medical cannabis product approved and imported for use in?Paraguay?for compassionate?use with a prescription and government permission. This event marked the third time in a little over a year that RSHO? was the first cannabis product approved in a Latin American country, following the lead of?Brazil?and?Mexico.